Jeppe Bennekou Schroll serves as a Clinical Associate Professor in the Department of Clinical Medicine at the University of Copenhagen's Faculty of Health and Medical Sciences, based at Blegdamsvej 3, 2200 Copenhagen N, Denmark. His research expertise spans: Gynecology and Obstetrics Cervical Cancer Screening methodologies HPV Vaccination impact assessment Women's Urological Health Elderly Women's Gynecological Care Population-based Medical Research Dr. Schroll's 2025 publications demonstrate a concentrated focus on evidence-based gynecological interventions using Danish population data. His work bridges clinical practice and public health through cohort studies on HPV vaccination efficacy, surgical outcomes in elderly patients, and innovative non-surgical treatments for urinary incontinence. The research consistently employs robust methodologies including population registries and randomized controlled trials, with significant media coverage across 14 news outlets and social platforms.
Vanessa Samouëlian, MD, PhD, serves as an Associate Clinical Professor in the Department of Obstetrics and Gynecology at the University of Montreal. Based at the Montreal University Hospital Center (CHUM), she specializes in gynecological oncology within the Gynecological Oncology division. Her institutional roles include leading Tumor Board meetings and serving as a service representative on CHUM's medical act evaluation committee and the University of Montreal externship committee. Her educational background includes: MD from University of Montpellier 1, France (1992-1998) Certificate of Clinical and Therapeutic Synthesis and Master's in Biological/Medical Sciences (1998) IUD in Colposcopy and Cervicovaginal Pathology (1999) DES in Gynecology-Obstetrics from University of Lille 2, France (2005) PhD from Biology-Health Doctoral School, University of Lille 2 (2007) Clinical Fellowship in Gynecology Oncology at CHUM (2009-2011) Dr. Samouëlian's research centers on gynecological malignancies with emphasis on cervical, endometrial, and vulvar cancers. She investigates molecular biomarkers for nodal metastasis, treatment outcomes in high-risk endometrial carcinoma, and surgical innovation including robotic techniques. Her work bridges clinical oncology, cancer pathology, and HPV vaccination strategies through national collaborations. Her 2015-2016 publications reveal a cohesive research trajectory focused on endometrial cancer through the Canadian High Risk Endometrial Cancer (CHREC) Consortium. Key themes include adjuvant therapy optimization, pathological pattern analysis (MELF invasion), and surgical training innovation using virtual reality simulation. These works demonstrate integration of clinical practice, molecular diagnostics, and surgical education within gynecologic oncology. Within CHUM's organizational structure, Dr. Samouëlian contributes to the Historical Assignment Team and Gynecological Oncology division. She co-developed the Contemporary Clinical Questions on HPV-Related Diseases and Vaccination booklet with Gynecologic Oncology Canada and Merck Canada, endorsed by major Canadian gynecological societies including the Society of Obstetricians and Gynaecologists of Canada.
Lars Engstrand is a Professor in infection control at Karolinska Institutet, heading the Translational Microbiome Research and Pandemic Preparedness group within the Department of Microbiology, Tumor and Cell Biology. His research spans multiple disciplines with a focus on translational microbiome research and pandemic preparedness. Engstrand's research interests center on understanding the human microbiome's role in health and disease, particularly in women's reproductive health and gastroenterology. His group has established multiple large-scale clinical studies including SweMaMi (Swedish Maternal Microbiome project), BASIC (associations between microbiota and preterm birth), VaMiGyn (Vaginal Microbiota in Gynaecological health), and several others investigating the vaginal microbiome's relationship to pregnancy outcomes, HPV infection, and cervical cancer. His team also conducts significant research on gut microbiome in inflammatory bowel disease and colorectal conditions through projects like PopCol and KOLBIBAKT. Analysis of Engstrand's most recent publications reveals a strong focus on the relationship between microbiome composition and women's health outcomes. His research consistently examines how vaginal, gut, and oral microbiomes influence pregnancy complications, preterm birth, HPV infection, and mental health during pregnancy. The work often employs large cohort studies with comprehensive sampling strategies across multiple body sites and time points, providing robust data for understanding microbiome dynamics in health and disease. Engstrand leads the Microbiome Exploration and Development for Intervention (MEDI) initiative and the National Pandemic Center (NPC) at Karolinska Institutet. The NPC conducted large-scale sequencing during the COVID-19 pandemic and has amassed over 1.5 million samples. His research group includes multiple specialized teams focusing on culturomics, bioinformatics, labcore operations, women's health research, and pandemic preparedness.
Dr. Jacques Archambault is a Professor in the Department of Microbiology and Immunology at McGill University , and an associate member of the Division of Experimental Medicine since 2016. His research focuses on the molecular biology and pathogenesis of human papillomaviruses (HPVs) and polyomaviruses (HPyVs), with an emphasis on their replication mechanisms as episomes in host cells. The Archambault laboratory employs functional genomics, proteomics, and chemical biology approaches to identify cellular pathways exploited by these viruses and develop high-throughput assays for screening small molecule inhibitors of viral replication. Analysis of his recent publications reveals a strong focus on HPV and HPyV replication machinery, including studies on the E1 helicase, UAF1-USP1 interactions, and structural characterization of viral proteins involved in DNA replication. His work bridges virology, oncology, and drug discovery, particularly targeting oncogenic HPV types implicated in anogenital and oropharyngeal cancers, as well as HPyVs like BKPyV and JCPyV that cause pathologies in immunosuppressed patients. Current efforts in the lab aim to elucidate the molecular mechanisms by which HPVs and HPyVs replicate their genomes and to develop antiviral therapies targeting these processes. Techniques such as fluorescence anisotropy, NMR spectroscopy, and crystallography are frequently employed to study protein-DNA and protein-protein interactions critical to viral replication.
Joseph Kangmennaang is an Assistant Professor and Queen's National Scholar in Black Health & Social Change at Queen's University. He holds a PhD from the University of Waterloo, an MA from Western University, and a B.A. from the University of Ghana. His research focuses on the interplay between environment and wellbeing, particularly in sub-Saharan Africa and among Black immigrant communities in North America. He employs social theories, participatory methods, and mixed approaches to address health disparities, with a focus on non-communicable diseases, food/water security, and the impact of racism and social change. His courses include HLTH 397 (Globalization and Black Health) and HLTH 495 (Racism and Health). Research areas include immigrant health equity, syndemics, and the role of place in healthcare access. Collaborations with marginalized communities emphasize participatory action and civic engagement. He has published extensively on topics such as climate change impacts on health, HIV/AIDS knowledge among women in Malawi, and the social determinants of wellbeing in Ghana. His work bridges global health challenges with localized solutions, addressing systemic inequities through interdisciplinary partnerships. Notably, he explores how structural factors like migration, remittances, and agroecology affect household welfare and food security in Malawi and Ghana. His recent studies highlight the mental health implications of discrimination among minoritized Canadians during the pandemic and the spatial distribution of diseases like cholera in Tanzania. He advocates for community-driven interventions to promote wellbeing in resource-limited settings.
Associate Professor Ernest Ekpo is affiliated with the University of Sydney's Sydney School of Health Sciences, within the Discipline of Medical Imaging Sciences. He holds academic roles as a Scholarly Teaching Fellow and Co-Director of the Medical Image Optimisation and Perception Group (MIOPeG). He is also an Associate Editor of the Journal of Medical Imaging and Radiation Sciences and a member of the Sydney Southeast Asia Centre and Cancer Research Network. Education: Earned BSc (Hons) in Radiography/Sonography from the University of Calabar, Nigeria, and a PhD from the University of Sydney. His research focuses on breast density, cancer biomarkers, medical image perception, radiation dose optimization, and radiology education. He explores applications in low-resource settings and emerging technologies like AI for diagnostic accuracy. Research interests include breast cancer treatment outcomes, image-based phenotypes, and improving imaging pathways for acute abdominal pain. Key themes are Cancer and Medical Imaging, with an emphasis on Women's Health and Chronic Disease. His work combines clinical practice, public health strategies, and technological advancements to enhance diagnostic efficacy and reduce unnecessary procedures. Articles from 2021–2024 highlight his contributions in mammography optimization, radiographer training, and AI-driven diagnostic tools. Recent grants include a 2024 project on CT examination education and a 2023 initiative to streamline breast cancer screening pathways. His awards recognize peer review excellence, early-career teaching, and research leadership. He supervises multiple students investigating breast density biomarkers, imaging modalities for dense breasts, and radiation dose management. His educational efforts aim to improve radiographers' capabilities in identifying urgent findings across CT and X-ray modalities, leveraging blended learning approaches.
Dr. Charlotte Kuperwasser is a distinguished Professor in the Department of Developmental, Molecular, and Chemical Biology at Tufts University School of Medicine . She directs the Tufts Convergence Laboratory and focuses on molecular mechanisms governing breast tissue development, cancer prevention, and organoid technologies. Her work integrates stem cell biology, epigenetics, and environmental influences such as endocrine disruptors. Education: Bachelor of Science (1997), University of Massachusetts Amherst PhD (2000), University of Massachusetts Amherst Jane Coffin Childs Postdoctoral Fellow (MIT/Whitehead Institute) Research Interests: Her lab develops 3D breast organoid models to study cancer initiation, microenvironmental interactions, and BRCA1-related mechanisms. Recent efforts include analyzing HPV-driven cancers via circulating tumor DNA and studying fibroblast signaling (e.g., DDR1) in tumor progression. Grants & Awards: Howard Hughes Fellowship, Merck Fellowship COG/Aventis Young Investigator Award Natalie V. Zucker Award NIH grants on V-ATPases and obesity-cancer links Professional Contributions: She chairs Tufts’ Sackler Convergence Laboratory and serves on AACR committees. Teaching includes courses on Molecular Cell Biology of Development and Cancer Genetics . Labs/Teams: Leads the Kuperwasser Lab, focusing on translational cancer research with cross-disciplinary collaborations in organoid engineering and clinical diagnostics.
Robert L. Murphy is the John Philip Phair Professor of Infectious Diseases and Professor of Biomedical Engineering at Northwestern University. He directs the Institute for Global Health within the Institute for Public Health and Medicine. His roles include leadership in global health research, infectious disease management, and biomedical engineering. Murphy holds appointments in the Feinberg School of Medicine and McCormick School of Engineering. Education: MD from Loyola University Stritch School of Medicine (1978), Fellowship, Residency, and Board Certification in Internal Medicine at Northwestern University (1981–1984). Research focuses on HIV/AIDS, viral hepatitis, antiviral therapies, and global health disparities. He leads projects in Nigeria, Mali, and other regions, addressing liver fibrosis in HIV/HBV co-infection, cervical cancer in HIV-positive women, and SARS-CoV-2 diagnostics. His work emphasizes point-of-care technologies and epigenetic biomarkers for cancer and liver disease. Publications span over 40 years, with recent emphasis on Omicron variant dynamics, HPV screening in resource-limited settings, and microbiome impacts of antiretroviral therapy. He collaborates globally, co-leading studies on tuberculosis treatment and HIV/drug resistance patterns. Grants and collaborations include the BRAINS faculty development program in Africa, the Test Us Bank (TUB) biorepository for SARS-CoV-2 samples, and partnerships with institutions like the University of Lagos and the Robert H. Lurie Comprehensive Cancer Center.
Mark Dignan, Ph.D., is a Professor with joint appointments in Behavioral Science, Internal Medicine, and the College of Social Work at the University of Kentucky. He contributes to the Cancer Prevention and Control Research Program, Center for Appalachian Research in Environmental Sciences (UK-CARES), and UNITE Research Priority Area, focusing on reducing health disparities in rural and underserved communities. Doctor of Philosophy, University of Tennessee-Knoxville (1977) Master of Public Health, University of North Carolina (1982) Master of Science, University of Utah (1974) Bachelor of Science, University of Utah (1973) His research evaluates community-based screening and early detection interventions, particularly for cervical, colorectal, and breast cancers. He specializes in health equity, tobacco control, and digital health strategies for rural populations, aligning with UN Sustainable Development Goals related to health and well-being. Recent work includes HPV self-collection programs, digital health interventions for colorectal cancer screening, and behavioral studies during the COVID-19 pandemic. His projects often involve collaborations with state health departments and the National Cancer Institute. R. Davilene Carter Presidential Prize for Best Manuscripts (2012, 2013, 2016, 2017, 2021) University Research Professor Award (2012) Current projects include statewide tobacco control evaluations and multi-institutional trials for cancer screening. He has led over 220 grants and 258 research outputs, emphasizing translational research and community engagement.
Dr. Marla Keller is a tenured Professor of Medicine and Obstetrics & Gynecology at Albert Einstein College of Medicine, currently serving as Executive Dean and holder of the Jacob and Jeanne Barkey Chair in Medicine. Director, NIH-funded Harold and Muriel Block Institute for Clinical and Translational Research Interim Senior Associate Dean for Clinical and Translational Research Vice Chair of Research for Department of Medicine Dr. Keller's research focuses on: Biomedical HIV prevention strategies Vaginal microbicide development PrEP implementation in women Cervical cancer screening in HIV+ women Immune responses to SARS-CoV-2 COVID-19 clinical trials Her recent publications emphasize: HPV infection and cervical precancer Vaginal microbiome interactions PrEP delivery systems HIV/HSV coinfection dynamics Convalescent plasma therapy Metronidazole treatment response Key scientific awards include: Infectious Disease Mentoring Award (2013) COVID-19 Distinguished Service Award (2021) Spirit of Achievement Changemaker Award (2023) New York Super Doctor (2011-2015)
Nathorn Chaiyakunapruk is a Professor in the Department of Pharmacotherapy at the University of Utah College of Pharmacy . He holds an adjunct appointment in Population Health Sciences and serves on multiple institutional committees including the Global Health Steering Committee and Health Economics Core at CTSI . His academic leadership extends to international roles with the World Health Organization and founding initiatives like the ISPOR Asia Consortium . Education : PhD in Pharmaceutical Outcomes Research, University of Washington PharmD, University of Wisconsin-Madison BS in Pharmaceutical Science, Chulalongkorn University Research Interests span health technology assessment , global health economics , and evidence synthesis . His work applies methodologies like network meta-analysis and umbrella reviews to address health equity, infectious disease modeling, and pharmaceutical policy. Recent studies focus on social determinants of health and vaccine economic value . Article Trends highlight collaborations in AI-assisted systematic reviews , vaccine rollout optimization , and health disparities . His publications frequently address cost-effectiveness and global health burden across infectious and non-communicable diseases. Scientific Awards : Senior Class (P4) Distinguished Teacher (2022) NRCT Outstanding Research Award (2019, 2012) Monash University PVC Research Award (2015) Nagai Research Foundation Awards (2006-2010) ISPOR Task Force Leadership (CHEERS 2022) Teaching & Service : Courses include Systematic Review and Meta-analysis and Global Health Policy . He chairs the Asia Pacific Evidence-based Medicine Network and advises WHO on vaccine economics and Thailand’s National Health Security Office on pharmaceutical policy.
Eva Lindberg is a Professor at the Department of Medical Sciences , Uppsala University , specializing in Lung, Allergy, and Sleep Research . She has contributed extensively to understanding the interplay between sleep-related disorders and respiratory/cardiovascular health. Research Themes : Sleep apnea, COPD, asthma, cardiometabolic risks, population-based studies. Key Collaborations : RHINESSA, SCAPIS, MUSTACHE cohorts. Her 2025 publications focus on cardiovascular consequences of sleep apnea, proteomic associations in lung disease, and cancer risks linked to nocturnal breathing disorders. Earlier work (2024–2022) examines obesity, physical activity, and environmental factors in sleep and respiratory health. Eva Lindberg is actively involved in clinical trials for sleep apnea interventions, including behavioral medicine and device-based therapies. She emphasizes sex-specific differences in sleep disorder diagnosis and outcomes.
Dr. Karen Yeates is a Professor in the Division of Nephrology at Queen's University's School of Medicine. She holds cross-appointments in the Faculty of Health Sciences and is a member of Queen's Cancer Research Institute and Translational Institute of Medicine. Her work focuses on improving healthcare access through mHealth innovations in global settings, particularly sub-Saharan Africa and Indigenous communities. Education: MD (Queen's University), MPH (Harvard School of Public Health), Fellowship in Nephrology (Royal College of Physicians and Surgeons Canada). Research interests span global health equity, cardiovascular disease prevention, cervical cancer screening, and mobile health technology. Key projects include leading the PURE Study Tanzania (Prospective Urban and Rural Epidemiology) and the International Polypill Study for cardiovascular prevention. She pioneered smartphone-based interventions for hypertension management in rural communities and cervical cancer screening in Tanzania. Articles consistently address mHealth implementation, chronic disease epidemiology, and health systems strengthening. Recent work evaluates mobile health tools for malaria prevention and cervical precancer detection in resource-limited settings. Rising Stars in Global Health Award (2024) CIHR-Global Alliance grant for mHealth hypertension projects Principal Investigator for Grand Challenges Canada initiatives Advocates for equitable kidney care globally, contributing to ISN Global Kidney Health Atlas. Co-founded Queen’s University School of Medicine’s Office of Global Health to advance interdisciplinary global health training.
Mimi (Paulomi) Bhatt, PhD, MPH, CNM, is an Assistant Professor at NYU Rory Meyers College of Nursing. She is a certified nurse-midwife, researcher, educator, and theorist whose work centers on birth equity, reproductive justice, and the integration of midwifery care in public health systems. She actively provides clinical care within NYC Health + Hospitals and contributes to national and global maternal health policy. PhD in Nursing Theory, NYU Meyers College of Nursing MSN, Frontier Nursing University MPH in Global Health Leadership, NYU Global Institute of Public Health BSN, NYU Steinhardt School of Education BA in Comparative Literature and English Education, NYU College of Arts & Science Dr. Bhatt’s research is grounded in critical feminist theory and qualitative methodologies. Her work investigates how midwifery models can advance health equity, particularly for Black, Indigenous, and other minoritized communities. She explores themes such as autonomy in childbirth, respectful maternity care, perinatal mental health, and systemic barriers faced by midwives of color. Her scholarship emphasizes anti-oppression frameworks and community-based participatory research. Her recent publications analyze experiential outcomes in maternity care, revealing that midwife-led care—especially in community settings—leads to higher autonomy, respect, and lower mistreatment. She has also published on the experiences of sexual and gender-diverse parents, cervical cancer screening in the Dominican Republic, and midwifery integration in India. Her work consistently highlights structural inequities and advocates for transformative change in maternal health systems. Scientific awards and honors include: NYU University-wide Dissertation Award – Allied Health & Social Services (2020) Jonas Nurse Leaders Scholar Award (multiple years) Johnson & Johnson Minority Faculty Nurse Scholar Award (multiple years) Herman Biggs Health Policy Fellow Women’s Leadership Initiative at NYU Dr. Bhatt mentors future nurse-midwives and contributes to policy through service on the NYC Maternal Mortality and Morbidity Review Committee and the International Confederation of Midwives’ Americas Regional Committee. She received postdoctoral training at the Birth Place Lab, University of British Columbia, and as a Provost Postdoctoral Fellow at NYU. Her clinical and academic work is deeply informed by her identity as a first-generation immigrant and her mother’s legacy as a nurse-midwife in India. She is affiliated with the Birth Place Lab and collaborates with multidisciplinary teams focused on respectful maternity care, midwifery practice climate, and global maternal health capacity building.
Dr. Svetlana Yanushkevich is a Professor in the Department of Electrical and Software Engineering at the Schulich School of Engineering, University of Calgary. She is also a Full Member of the Hotchkiss Brain Institute and the Mathison Centre for Mental Health Research and Education. Her research focuses on biometric technologies, decision support systems, biomedical applications, and computational intelligence. She leads the Biometric Technologies Laboratory, developing strategies for risk assessment in biometric systems and healthcare monitoring through machine reasoning and signal processing. Education : BSc/MSc in Electrical Engineering (1989), State University of Informatics and Radioelectronics, Minsk PhD in Electrical Engineering (1992), same institution Dr. Habilitated in Technical Sciences (1999), Warsaw University of Technology Research Interests : Dr. Yanushkevich’s work spans biometric system design (e.g., gait analysis, facial attributes), decision support via probabilistic models (Bayesian networks, causal inference), biomedical applications (stroke rehabilitation, wearable sensors), and computational intelligence for data science. She emphasizes fairness, bias mitigation, and trustworthiness in AI systems, particularly in healthcare and accessibility contexts. Recent Research Trends : Her recent publications address causal modeling for accessibility barriers, UAV operator cognitive workload, and medical device optimization in radiation therapy. She explores AI ethics, stress contagion in human-robot teams, and cross-spectral biometric systems. Awards & Recognition : 2024 FEIC Fellow (Engineering Institute of Canada) 2019 Research Excellence Award (Schulich School of Engineering) 2001 Senior IEEE Membership Advising & Grants : She coordinates courses like ENCM 509 (Biometric Systems Design) and ENEL 610 (Biometric Technologies). Her research is supported by grants focusing on healthcare AI, accessibility technologies, and computational epidemiology. Labs & Collaborations : Her Biometric Technologies Lab collaborates with institutions like Hokkaido University and the IEEE Computational Intelligence Society. Projects include wearable health monitoring, decision support platforms, and AI-driven epidemiological modeling.
